Mary Polan

Mary Lake Polan currently works at Motif BioSciences, Inc., as Non-Executive Director from 1993, Chembio Diagnostic Systems, Inc., as Director from 2018, NovaTract Surgical, Inc., as Director, NX Prenatal, Inc., as Director, Or-Genix Therapeutics, Inc., as Director, QuidelOrtho Corp., as Independent Director from 1993, National Academy of Medicine (United States), as Member, and Yale School of Medicine, as Professor from 2014.
Dr. Polan also formerly worked at Wyeth LLC, as Director from 1995 to 2009, Quidel Corp., as Independent Director, Chembio Diagnostics, Inc., as Independent Director from 2018 to 2021, Wyeth Pharmaceuticals LLC, as Director, EpiEP, Inc., as Director, MiraDx, Inc., as Director, Motif Bio Plc, as Independent Non-Executive Director from 2004 to 2019, Golden Seeds, Inc., as Managing Director, Stanford University School of Medicine, as Professor from 2005 to 2006, and Columbia University Vagelos College of Physicians & Surgeons, as Clinical Professor.
Dr. Polan received her undergraduate degree from Connecticut College, graduate degree from the University of California, Berkeley, and doctorate degree from Yale School of Medicine.